
Experimental Treatment Shows 90% Success Rate Against Cancer
Hadassah-University Medical Center in Jerusalem has achieved a groundbreaking feat in the treatment of multiple myeloma, meaning the second-most common blood cancer. Through an innovative approach utilizing CAR-T (Chimeric Antigen Receptor T-Cell) therapy, which enhances the immune system of the…













